Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

HUTCHMED (China) Limited - American Depositary Shares (NQ:HCM)

14.32 +0.06 (+0.42%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 26, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	13,187
Open	14.40
Bid (Size)	14.02 (2,100)
Ask (Size)	15.30 (100)
Prev. Close	14.26
Today's Range	14.19 - 14.40
52wk Range	11.51 - 19.50
Shares Outstanding	871,256,270
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

November 05, 2025

Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO® Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO®

November 04, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

Performance

YTD	-5.0%	-5.0%
1 Month	-3.6%	-3.6%
3 Month	-8.4%	-8.4%
6 Month	+6.8%	+6.8%
1 Year	-17.7%	-17.7%

More News

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event

November 02, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025

October 31, 2025

From Virtual Investor Conferences

Via GlobeNewswire

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025

October 30, 2025

From Virtual Investor Conferences

Via GlobeNewswire

HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 22, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

October 14, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress

October 13, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2025

October 01, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

IBEX, Tesla, IonQ, Warner Bros. Discovery And Other Big Stocks Moving Higher On Friday ↗

September 12, 2025

Via Benzinga

Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025

September 11, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025

September 04, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Announces Appointment of Acting Chief Executive Officer

August 24, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China

August 19, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Reports 2025 Interim Results

August 07, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED to Announce 2025 Half-Year Financial Results

July 03, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy

June 30, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

Hutchmed Stock Hits Over One-Month High After China Accepts Kidney Cancer NDA Filed With Partner Innovent Biologics ↗

June 04, 2025

Via Stocktwits

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma

June 04, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting

June 01, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting

May 22, 2025

From HUTCHMED (China) Limited

Via GlobeNewswire

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

May 16, 2025

From Virtual Investor Conferences

Via GlobeNewswire

UPDATE - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

May 08, 2025

From Virtual Investor Conferences

Via GlobeNewswire

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

May 08, 2025

From Virtual Investor Conferences

Via GlobeNewswire

Frequently Asked Questions

Is HUTCHMED (China) Limited - American Depositary Shares publicly traded?

Yes, HUTCHMED (China) Limited - American Depositary Shares is publicly traded.

What exchange does HUTCHMED (China) Limited - American Depositary Shares trade on?

HUTCHMED (China) Limited - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for HUTCHMED (China) Limited - American Depositary Shares?

The ticker symbol for HUTCHMED (China) Limited - American Depositary Shares is HCM on the Nasdaq Stock Market

What is the current price of HUTCHMED (China) Limited - American Depositary Shares?

The current price of HUTCHMED (China) Limited - American Depositary Shares is 14.32

When was HUTCHMED (China) Limited - American Depositary Shares last traded?

The last trade of HUTCHMED (China) Limited - American Depositary Shares was at 11/26/25 04:00 PM ET

What is the market capitalization of HUTCHMED (China) Limited - American Depositary Shares?

The market capitalization of HUTCHMED (China) Limited - American Depositary Shares is 12.48B

How many shares of HUTCHMED (China) Limited - American Depositary Shares are outstanding?

HUTCHMED (China) Limited - American Depositary Shares has 12B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.